Watchful Waiting: Clinical Trials

544 trials of Watchful Waiting, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

207 completed, 114 recruiting, 96 unknown, 45 active not recruiting. 79 Not applicable, 52 Phase 3, 45 Phase 2, 6 Phase 1, 5 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable79Completed 24, Recruiting 20, Unknown 14, Terminated 7, Active not recruiting 6, Withdrawn 4, Not yet recruiting 2, Enrolling by invitation 1, Suspended 1
Phase 352Active not recruiting 17, Completed 13, Recruiting 12, Not yet recruiting 4, Unknown 4, Terminated 1, Withdrawn 1
Phase 245Recruiting 14, Active not recruiting 8, Completed 6, Terminated 6, Unknown 5, Not yet recruiting 3, Suspended 2, Withdrawn 1
Phase 16Terminated 3, Active not recruiting 2, Unknown 1
Early Phase 15Recruiting 2, Active not recruiting 1, Terminated 1, Unknown 1
Phase 44Completed 2, Not yet recruiting 1, Recruiting 1

Follow Watchful Waiting: new trials by email Literature Review of Watchful Waiting trials Research Report on Watchful Waiting

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Biospecimen Collection, Chest Radiography, Computed Tomography - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8
Phase 2RecruitingChildren's Oncology Group512027-05-152026-09-24
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Atezolizumab, Atezolizumab and Recombinant Human Hyaluronidase, Biospecimen Collection - Lung Non-Small Cell Carcinoma
Phase 3RecruitingNational Cancer Institute (NCI)3362027-03-022026-11-18
Polatuzumab Vedotin, Mosunetuzumab, and Acalabrutinib for the Treatment of Mantle Cell Lymphoma, PAcMan Trial
Polatuzumab Vedotin, Acalabrutinib, Mosunetuzumab - Mantle Cell Lymphoma
Phase 2Not yet recruitingUniversity of Washington272027-03-012026-11-02
Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain
Biospecimen Collection, Low-Dose Aspirin, Patient Observation - Endometrial Carcinoma
Phase 4Not yet recruitingMayo Clinic202027-02-122026-08-05
Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma
Biospecimen Collection, Bone Scan, Computed Tomography - Non-Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 3Not yet recruitingNational Cancer Institute (NCI)4002027-02-102026-07-08
Comparing Radiation After Surgery to Observation After Surgery in Patients With Clinical Low-Risk, Molecular High-Risk Meningioma, and Evaluating Observation After Surgery in Patients With Clinical and Molecular Low-Risk Meningioma
Patient Observation, Magnetic Resonance Imaging, Biospecimen Collection - Grade 1 Meningioma, Grade 2 Meningioma
Phase 3Not yet recruitingNRG Oncology4642027-01-282026-08-25
Screen Time Exposure and Behavioral Outcomes
No intervention (observational study), Observational - Screen Time Exposure and Behavioral Outcomes
Not yet recruitingSohag University6002026-12-012026-11-19
C2001P-CS3: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV
HPV DNA Testing (Abbott Alinity m HPV Assay), Visual Inspection with Acetic Acid, Cervical Histology (Biopsy Procedures) - Human Papillomavirus (HPV), HPV Associated Cancers
Not applicableRecruitingUniversity of California, San Diego7502026-11-092026-11-12
A Pragmatic Study of MRD-Guided Maintenance for Multiple Myeloma in Latin America
MRD-Guided Maintenance Discontinuation and Active Surveillance - MRD-Guided Maintenance for Multiple Myeloma in Latin America
Not applicableNot yet recruitingHospital Universitario Dr. Jose E. Gonzalez622026-11-012026-11-19
Co-Existent Endometrial and Ovarian Carcinoma: Molecular Stratification for Pathologic Reporting and Clinical Management
Treatment De-escalation, Additional Treatment - Co-existent Endometrial and Ovarian Carcinoma, Ovarian Carcinoma
Phase 2Not yet recruitingBritish Columbia Cancer Agency902026-10-302026-11-16
C2001P-CS6: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV
HPV DNA Testing (Abbott Alinity m HPV Assay), Visual Inspection with Acetic Acid, Cervical Histology (Biopsy Procedures) - Human Papillomavirus (HPV), HPV Associated Cancers
Not applicableRecruitingUniversity of California, San Diego7502026-10-162026-11-09
Titanium Particle Release Across Non-Surgical Peri-implantitis Therapies
Mechanical Debridement with Titanium Curettes, Mechanical Debridement with Plastic Curettes, 940 nm Diode Laser Decontamination - Peri-implantitis
Not applicableRecruitingSaglik Bilimleri Universitesi702026-10-152026-11-17
A Study to Evaluate the Analgesic Properties of Topically Applied Menthol in Marathon Participants
Observational, Non-Interventional Study - Muscle Soreness
CompletedReckitt Benckiser Healthcare (UK) Limited6872026-10-112026-11-06
Long-Term Follow-Up Study of Gamgertamig
Observational - Autoimmune Cytopenias
Not yet recruitingLakefront Biotherapeutics West LLC1002026-10-012026-09-29
Comparing Surgical and Nonsurgical Outcomes of Cubital Tunnel Syndrome
Cubital tunnel release, Conservative Arm - Cubital Tunnel Syndrome
Not applicableNot yet recruitingUniversity of Pittsburgh2202026-10-012026-10-20
WATER IV PCa (AS Sub-study)
Aquablation Therapy, Active Surveillance - Localized Prostate Cancer
Not applicableRecruitingPROCEPT BioRobotics3332026-09-112026-11-06
Adjuvant Trial in Pancreatic Neuroendocrine Tumors
Adjuvant chemotherapy with Capecitabine-Temozolomide, Active surveillance - Pancreatic Neuroendocrine Tumors (pNET), Pancreatic Neuroendocrine Tumors
Phase 3Not yet recruitingGustave Roussy, Cancer Campus, Grand Paris3002026-09-012026-05-15
Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
Active Surveillance With ctHPVDNA (NavDx®) - Squamous Cell Carcinoma, Human Papilloma Virus (HPV)
Phase 2RecruitingMedical University of South Carolina362026-08-122026-09-14
Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC
Active Surveillance, Adjuvant Intravesical Chemotherapy - Bladder Cancer, Non-Muscle-Invasive Bladder Cancer (NMIBC)
Not applicableRecruitingTianjin Medical University Second Hospital6702026-08-102026-10-09
The Mother-Daughter Project: Merck-4
Gardasil-9, High Risk HPV DNA Testing, Visual Inspection with acetic acid (VIA) and possible cervical biopsy - Cervical Dysplasia
Not applicableRecruitingIndiana University25002026-07-222026-11-10

Showing 20 of 544. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (26)  ·  Breast Neoplasms (13)  ·  COVID-19 (13)  ·  Carcinoma, Non-Small-Cell Lung (13)  ·  Neoplasms (13)  ·  Obesity (11)  ·  Colonic Neoplasms (9)  ·  Diabetes Mellitus, Type 2 (8)  ·  Motor Activity (8)  ·  Pulmonary Disease, Chronic Obstructive (8)  ·  Uterine Cervical Neoplasms (8)  ·  Cardiovascular Diseases (7)  ·  Heart Failure (7)  ·  Carcinoma, Renal Cell (6)  ·  Colorectal Neoplasms (6)

Sponsors

National Cancer Institute (NCI) (19)  ·  Mayo Clinic (10)  ·  Children's Oncology Group (8)  ·  Columbia University (6)  ·  Duke University (6)  ·  HaEmek Medical Center, Israel (6)  ·  M.D. Anderson Cancer Center (6)  ·  Abant Izzet Baysal University (5)  ·  Alliance for Clinical Trials in Oncology (5)  ·  Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis (5)  ·  Centre Hospitalier de Cayenne (5)  ·  NRG Oncology (5)  ·  Roswell Park Cancer Institute (5)  ·  University of Pennsylvania (5)  ·  City of Hope Medical Center (4)

Countries

United States (210)  ·  Canada (56)  ·  United Kingdom (39)  ·  France (37)  ·  China (33)  ·  Italy (27)  ·  Turkey (Türkiye) (21)  ·  Spain (20)  ·  Netherlands (16)  ·  Germany (15)  ·  Australia (14)  ·  Puerto Rico (14)  ·  Denmark (12)  ·  Belgium (10)  ·  Israel (9)

Top investigators

Olivier Beauchet, MD (3)  ·  Amy Jamieson (2)  ·  Andrea B. Goldschmidt, Ph.D. (2)  ·  Ariel Koren, MD (2)  ·  Carina Levin, MD (2)  ·  Jacqueline Montes, PT, EdD (2)  ·  Jessica McAlpine (2)  ·  Kishore Mulpuri, FRCSC (2)  ·  Leticia Castillo, M.D. (2)  ·  Marcelo A Holanda, PHD (2)  ·  Matthew Crotty, PharmD (2)

Results publications

PMID 35554583, PMID 10914623, PMID 11112239, PMID 11459755, PMID 11775787, PMID 11832252, PMID 11843075, PMID 12127181, PMID 14586353, PMID 14599700, PMID 15021773, PMID 15449976, PMID 15454805, PMID 16055573, PMID 16307931, PMID 16418463, PMID 16522419, PMID 16908781, PMID 16921051, PMID 17084135, PMID 17110646, PMID 17161082, PMID 17239183, PMID 17289240, PMID 17621365, PMID 17650692, PMID 17786808, PMID 17825674, PMID 17897924, PMID 1798888, PMID 18053373, PMID 18058946, PMID 18408401, PMID 18408402, PMID 18626005, PMID 19026961, PMID 19038077, PMID 19129538, PMID 19249635, PMID 19457604, PMID 19893191, PMID 19918928, PMID 20132984, PMID 20360052, PMID 20430946, PMID 20448073, PMID 20522709, PMID 20823433, PMID 20876603, PMID 21098350

NIH funding

U10CA180820 (10), U10CA180886 (7), U10CA180821 (6), U10CA180868 (6), U10CA021115 (4), U10CA031946 (4), U10CA098543 (4), U10CA180888 (4), P30CA033572 (3), U10CA027469 (3), U10CA180830 (3), 2019 (2), P30CA014599 (2), P30CA016056 (2), P30CA138292 (2)